Roche Holding AG EBS · ROP.SW
Price alert —
Sign in to get a one-time email the moment ROP.SW crosses your price. Free accounts included.
Sign in / create a free accountRoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP.SW last traded at $333.80, up 0.6% on the day; that's in the middle part of its 52-week range ($291.00–$374.90). Right now it's trading close to its recent average, with no strong stretch in either direction.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
below KC1 upper, +0.26 ATR from EMA21 — no notable pattern
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · Aligned with weak downtrend
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
ROP.SW is a $265.6 billion company, priced at 21× last year's earnings, and it moves more calmly than the market (beta 0.3).
Earnings
See more →- Last reported
- 2021-07-21
- EPS (act / est)
- 3.49 / 10.24
- Surprise
- -65.9%
- Next report
- 2026-07-23
About
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respirator…